Epigenetic mechanisms in cardiovascular complications of diabetes: towards future therapies

Ali HA, Li Y, Bilal AHM, Qin T, Yuan Z, Zhao W. A Comprehensive Review of BET Protein Biochemistry, physiology, and pathological roles. Front Pharmacol. 2022;13:818891.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Avrahami D, Kaestner KH. The dynamic methylome of islets in health and disease. Mol Metab. 2019;27S(Suppl):S25–32.

Article  PubMed  Google Scholar 

Bailey D, Jahagirdar R, Gordon A, Hafiane A, Campbell S, Chatur S, Wagner GS, Hansen HC, Chiacchia FS, Johansson J, et al. RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo. J Am Coll Cardiol. 2010;55(23):2580–9.

Article  CAS  PubMed  Google Scholar 

Bajbouj K, Al-Ali A, Ramakrishnan RK, Saber-Ayad M, Hamid Q. Histone modification in NSCLC: Molecular mechanisms and therapeutic targets. Int J Mol Sci 2021, 22(21).

Bhat A, Ghatage T, Bhan S, Lahane GP, Dhar A, Kumar R, Pandita RK, Bhat KM, Ramos KS, Pandita TK. Role of transposable elements in Genome Stability: implications for Health and Disease. Int J Mol Sci 2022, 23(14).

Biondi G, Marrano N, Borrelli A, Rella M, D’Oria R, Genchi VA, Caccioppoli C, Cignarelli A, Perrini S, Laviola L et al. The p66(shc) Redox Protein and the emerging complications of diabetes. Int J Mol Sci 2023, 25(1).

Borck PC, Guo LW, Plutzky J. BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs. Circ Res. 2020;126(9):1190–208.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Breschi A, Gingeras TR, Guigo R. Comparative transcriptomics in human and mouse. Nat Rev Genet. 2017;18(7):425–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bridgeman SC, Ellison GC, Melton PE, Newsholme P, Mamotte CDS. Epigenetic effects of metformin: from molecular mechanisms to clinical implications. Diabetes Obes Metab. 2018;20(7):1553–62.

Article  PubMed  Google Scholar 

Brown JD, Lin CY, Duan Q, Griffin G, Federation A, Paranal RM, Bair S, Newton G, Lichtman A, Kung A, et al. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell. 2014;56(2):219–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Camara AS, Mascher M. Consistencies and contradictions in different polymer models of chromatin architecture. Comput Struct Biotechnol J. 2023;21:1084–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cavalieri V. The Expanding Constellation of histone post-translational modifications in the Epigenetic Landscape. Genes (Basel) 2021, 12(10).

Cencioni C, Spallotta F, Greco S, Martelli F, Zeiher AM, Gaetano C. Epigenetic mechanisms of hyperglycemic memory. Int J Biochem Cell Biol. 2014;51:155–8.

Article  CAS  PubMed  Google Scholar 

Chang HY, Qi LS. Reversing the Central Dogma: RNA-guided control of DNA in epigenetics and genome editing. Mol Cell. 2023;83(3):442–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Zou Y, Song C, Cao K, Cai K, Wu Y, Zhang Z, Geng D, Sun W, Ouyang N, et al. The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. Basic Res Cardiol. 2023;118(1):48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cooper ME, El-Osta A. Epigenetics: mechanisms and implications for diabetic complications. Circ Res. 2010;107(12):1403–13.

Article  CAS  PubMed  Google Scholar 

Costantino S, Libby P, Kishore R, Tardif JC, El-Osta A, Paneni F. Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena. Eur Heart J. 2018;39(47):4150–8.

Article  CAS  PubMed  Google Scholar 

Dupont C, Armant DR, Brenner CA. Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med. 2009;27(5):351–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eberharter A, Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 2002;3(3):224–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ecker S, Pancaldi V, Valencia A, Beck S, Paul DS. Epigenetic and transcriptional variability shape phenotypic plasticity. BioEssays 2018, 40(2).

Eelen G, de Zeeuw P, Simons M, Carmeliet P. Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 2015;116(7):1231–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Osta A, Wolffe AP. DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease. Gene Expr. 2000;9(1–2):63–75.

CAS  PubMed  Google Scholar 

El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med. 2008;205(10):2409–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elbere I, Silamikelis I, Ustinova M, Kalnina I, Zaharenko L, Peculis R, Konrade I, Ciuculete DM, Zhukovsky C, Gudra D, et al. Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals. Clin Epigenetics. 2018;10(1):156.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Epidemiology of Diabetes I, Complications Research G. Epidemiology of diabetes interventions and complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and complications Trial cohort. Diabetes Care. 1999;22(1):99–111.

Article  Google Scholar 

Feng B, Ruiz MA, Chakrabarti S. Oxidative-stress-induced epigenetic changes in chronic diabetic complications. Can J Physiol Pharmacol. 2013;91(3):213–20.

Article  CAS  PubMed  Google Scholar 

Galimov ER. The role of p66shc in oxidative stress and apoptosis. Acta Naturae. 2010;2(4):44–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garmpi A, Damaskos C, Garmpis N, Kaminiotis VV, Georgakopoulou VE, Spandidos DA, Papalexis P, Diamantis E, Patsouras A, Kyriakos G, et al. Role of histone deacetylase inhibitors in diabetic cardiomyopathy in experimental models (review). Med Int (Lond). 2022;2(4):26.

PubMed  Google Scholar 

Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res. 2010;106(8):1319–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gilham D, Wasiak S, Tsujikawa LM, Halliday C, Norek K, Patel RG, Kulikowski E, Johansson J, Sweeney M, Wong NC, et al. RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease. Atherosclerosis. 2016;247:48–57.

Article  CAS  PubMed  Google Scholar 

Ginno PA, Lott PL, Christensen HC, Korf I, Chedin F. R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. Mol Cell. 2012;45(6):814–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giordo R, Posadino AM, Mangoni AA, Pintus G. Metformin-mediated epigenetic modifications in diabetes and associated conditions: Biological and clinical relevance. Biochem Pharmacol. 2023;215:115732.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif